Methotrexate vs lifestyle for RA

What the research found.

• Weight training lowered DAS-28 disease activity by 0.69 standard deviations, with the true value running from minus 1.26 to minus 0.11. That came from seventeen trials and 1,010 patients. All of them kept getting their usual care throughout.

  Wen and Chai, Medicine, 2021

• One trial gave people an anti-inflammatory diet and a control diet in turn, so each person ate both. The test it planned in advance found no difference in DAS28-ESR, at a P value of 0.116. The figure people quote comes from a different and unplanned test.

  Vadell and colleagues, The American Journal of Clinical Nutrition, 2020

• One review covered nutrition across rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis, and it's the largest one we hold. It found that its trials couldn't be pooled at all. So it reports a direction and gives no pooled effect size to go with it.

  Van den Bruel and colleagues, Frontiers in Medicine, 2025

• A healthy overall way of eating went with less new rheumatoid arthritis, at an odds ratio of 0.84 once the analysis was cut to the three studies at lowest risk of bias. That's a claim about developing the disease rather than treating it. The two questions have different literatures behind them.

  Joerns and colleagues, Seminars in Arthritis and Rheumatism, 2025

The short answer.

The comparison in the title has never been run. No trial has put a disease-modifying drug against a diet or an exercise program in people with rheumatoid arthritis, so there's no evidence supporting either side of that question. Anyone who tells you otherwise is describing something that hasn't been studied.

What has been studied is lifestyle added to treatment, and those results are real. Weight training lowered disease activity by 0.69 standard deviations across seventeen trials, and it lowered the sedimentation rate by 0.86. Every person in those trials kept taking their usual medication throughout.

The difference in the risks settles the practical question. Joint damage in rheumatoid arthritis is permanent and no treatment reverses damage that has already happened, so stopping a drug that works risks something lasting. Doing that to test an untested idea puts permanent harm on one side and an unproven benefit on the other.

Side by side.

The study that would answer this

One trial would settle the whole question. You would take people with rheumatoid arthritis, put some on diet and exercise at random, put the rest on methotrexate, and then follow them long enough to see what happened to their joints. That study hasn't been done, and no trial in this site's evidence base compares a lifestyle program against a disease-modifying drug.

That absence is the most important thing on this page, because it means claims in either direction are unsupported. So anyone saying food can replace a drug is describing something nobody has tested rather than describing what the research shows. The claim isn't wrong so much as unmade.

It also explains why the question feels open when the practical answer isn't. Nobody has run the comparison, and that isn't the same as running it and finding two treatments come out even. The difference between those two things counts a great deal when one of the choices risks something lasting.

What the lifestyle trials did measure

Weight training has the strongest result of anything here. It lowered DAS-28 disease activity by 0.69 standard deviations, from seventeen randomized trials and 1,010 patients, with the true value running from minus 1.26 to minus 0.11. The sedimentation rate fell by 0.86 standard deviations in the same review, and walking speed improved.

Those are real effects on the measures rheumatologists use, so take them seriously rather than waving them off as soft outcomes. What they aren't is evidence about swapping one thing for another. Every person in those trials kept getting usual care, so the comparison was exercise plus a drug against the drug alone.

The diet evidence for existing disease is weaker still. The best-known diet trial found no difference in its planned test, at a P value of 0.116, and the largest review here covered three inflammatory conditions and found its trials couldn't be pooled at all. So neither result supports dropping a drug.

The prevention and treatment confusion

There's good evidence that how you eat relates to whether you develop rheumatoid arthritis in the first place. One review looked at a healthy overall way of eating, where the odds ratio for new disease was 0.84 once the analysis was cut to the three studies at lowest risk of bias. A Mediterranean picture of eating came out at 0.88.

Those figures describe people who don't have rheumatoid arthritis, so they say something about the chance of developing it and nothing about controlling it once it's there. The two questions have different literatures and different study designs behind them. They also have different answers.

Writers slide from one to the other without flagging it, and that's the commonest error on this subject. It's how a modest prevention signal becomes an implied treatment claim. So watch for it when a page quotes a diet study at you about a disease you already have.

Why the risks aren't symmetrical

Joint damage in rheumatoid arthritis is permanent, and no treatment reverses damage that has already happened. The whole logic of early treatment is that it prevents damage rather than repairing it. That one fact makes this decision a good deal simpler than the uncertainty around it would suggest, and it's the reason the rest of the page reads the way it does.

Stopping a drug that works, in order to test an untested idea, puts lasting harm on one side and an unproven benefit on the other. So take somebody who is genuinely unsure how much her methotrexate is doing for her, and who has every reason to wonder. Even she should notice that the two possible mistakes cost very different amounts.

Nothing in that means a drug is forever, and it doesn't mean cutting one back is never right. Cutting a drug back in long remission is a real clinical question, it has protocols, it gets done with monitoring, and you can restart if the disease comes back. The difference between all of that and stopping on the strength of a website is supervision.

What to do with all of this

Take the medication your rheumatologist prescribed, and then use everything else on this page for what it clearly and separately does. Exercise improves disease activity, inflammation markers, function, and fitness, and all of that was measured in people who stayed on their treatment throughout. So exercise earns its place on its own terms, and it never has to stand in for anything else to be worth doing, which is a better argument for it than the one people usually reach for.

Use a Mediterranean-style diet for heart risk, which is raised in nearly every rheumatic condition. That benefit doesn't lean on the arthritis evidence at all, which is a large part of what makes it worth acting on. It's the strongest reason to eat that way whatever else turns out to be true about the joints.

If you want to reduce your medication, raise it as a question rather than acting on it by yourself in the meantime. Your rheumatologist has that conversation regularly and has protocols for it. It goes a great deal better when it starts early, and it goes badly once the drug has already been stopped.

When each one fits.

• Take the medication your rheumatologist prescribed, and treat everything on this page as work that goes alongside it.
• Use exercise for what it clearly does, meaning disease activity, the sedimentation rate, function, and fitness, all of which were measured in people who stayed on their treatment.
• Use a Mediterranean-style diet for heart risk, which is raised in this condition, rather than expecting it to control the arthritis.
• Raise a wish to cut your medication with your rheumatologist rather than acting on it alone, because cutting a drug back in long remission is a real clinical talk with a protocol behind it.
• If a source tells you food can replace a disease-modifying drug, it's describing a study nobody has done.

Questions patients ask.